Dare Bioscience, Inc. (DARE) vs IN8bio, Inc. (INAB)
A side-by-side comparison of Dare Bioscience, Inc. and IN8bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DARE
Dare Bioscience, Inc.
$0.84HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
INAB
IN8bio, Inc.
$1.43HealthcareDelayed quote: Oct 6, 2026, 11:52 AM EDT
Total return — DARE vs INAB
growth of $100 · dividends reinvested · last 5yDARE -95.1% (-45.2%/yr)INAB -99.5% (-65.7%/yr)DARE compounded faster over this window
Log scale — wide-divergence pair
DARE INAB
DARE vs INAB: by the numbers
- •INAB is the larger company ($14M vs $13M market cap).
- •Both run net losses; INAB's is the smaller (0.00% vs -804.37% net margin).
Metrics side by side
Valuation
| Metric | DARE | INAB |
|---|---|---|
| P/S ratio | 9.18 | N/A |
| P/B ratio | N/A | 0.75 |
Profitability
| Metric | DARE | INAB |
|---|---|---|
| Gross margin | -137.55% | 0.00% |
| Operating margin | -1315.51% | 0.00% |
| Net margin | -804.37% | 0.00% |
| ROE | N/A | -101.66% |
| ROIC | -203.50% | -91.74% |
Growth (annualized)
| Metric | DARE | INAB |
|---|---|---|
| Total return CAGR (5Y) | -46.35% | -62.88% |
Frequently asked
- How have DARE and INAB total returns compared?
- Over the past 5 years, DARE delivered -46.35% and INAB delivered -62.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.